Literature DB >> 8484373

Comparative epidemiology of Down syndrome in two United States population, 1970-1989.

E Krivchenia1, C A Huether, L D Edmonds, D S May, S Guckenberger.   

Abstract

This study compared the epidemiology of Down syndrome over a 20-year period, 1970-1989, in two populations in which livebirths with Down syndrome were believed to be highly ascertained. One population was a 10-county region in southwest Ohio; the second was a five-county region in metropolitan Atlanta, Georgia. The major objectives were to 1) compare observed incidences of Down syndrome over the entire study period; 2) calculate expected incidences of Down syndrome for each population and compare these with observed incidences; 3) determine incidence trends throughout the period; and 4) examine the impact of prenatal diagnosis on the observed incidence of Down syndrome in each population. Excluding aborted fetuses with Down syndrome diagnosed prenatally, the observed incidence of Down syndrome, 0.98, was significantly lower than that expected, 1.27, within the Atlanta white data set. Once the observed data were adjusted to include aborted fetuses with Down syndrome (total incidence = 1.17), no statistically significant differences remained. No differences were found between observed and expected incidences of Down syndrome for whites in southwest Ohio or for other races in either population. Although uncorrected observed incidences were significantly different between the two populations of whites for the entire 20-year period, the differences again disappeared after the data were corrected to include aborted fetuses. No significant effect of prenatal diagnosis on those of other races was found in either population. Expected Down syndrome incidences rose from the late 1970s throughout the 1980s for both racial groups in Ohio and Atlanta, Georgia; however, because the termination of fetuses with Down syndrome increased over the decade, the observed incidence among whites in southwest Ohio remained at earlier levels and actually fell among whites in Atlanta. These results indicate the increasing importance of prenatal diagnosis and selective abortion in the epidemiology of Down syndrome and of correcting for it when comparing incidences between populations, even within the same time period. These data from 2 decades show that differences in both observed and expected incidences of Down syndrome exist between both populations and races, principally because of differences in demographic age structure and maternal age fertility rates and because of differential use of prenatal diagnosis and selective abortion.

Mesh:

Year:  1993        PMID: 8484373     DOI: 10.1093/oxfordjournals.aje.a116743

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  10 in total

1.  Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

Authors:  B Khoshnood; P Pryde; S Wall; J Singh; R Mittendorf; K S Lee
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  Increasing total prevalence rate of cases with Down syndrome in Hungary.

Authors:  Julia Métneki; Andrew E Czeizel
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Maternal age specific risk rate estimates for Down syndrome among live births in whites and other races from Ohio and metropolitan Atlanta, 1970-1989.

Authors:  C A Huether; J Ivanovich; B S Goodwin; E L Krivchenia; V S Hertzberg; L D Edmonds; D S May; J H Priest
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

4.  Homocysteine metabolism in children with Down syndrome: in vitro modulation.

Authors:  M Pogribna; S Melnyk; I Pogribny; A Chango; P Yi; S J James
Journal:  Am J Hum Genet       Date:  2001-06-05       Impact factor: 11.025

5.  Trends in survival among children with Down syndrome in 10 regions of the United States.

Authors:  James E Kucik; Mikyong Shin; Csaba Siffel; Lisa Marengo; Adolfo Correa
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

6.  Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study.

Authors:  P W Yoon; S B Freeman; S L Sherman; L F Taft; Y Gu; D Pettay; W D Flanders; M J Khoury; T J Hassold
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

7.  Selected birth defects data from population-based birth defects surveillance programs in the United States, 2006 to 2010: featuring trisomy conditions.

Authors:  Cara T Mai; James E Kucik; Jennifer Isenburg; Marcia L Feldkamp; Lisa K Marengo; Erin M Bugenske; Phoebe G Thorpe; Jodi M Jackson; Adolfo Correa; Russel Rickard; C J Alverson; Russell S Kirby
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2013-11

8.  Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.

Authors:  Jodi M Jackson; Krista S Crider; Janet D Cragan; Sonja A Rasmussen; Richard S Olney
Journal:  Am J Med Genet A       Date:  2013-11-22       Impact factor: 2.802

9.  A mathematical model of glutathione metabolism.

Authors:  Michael C Reed; Rachel L Thomas; Jovana Pavisic; S Jill James; Cornelia M Ulrich; H Frederik Nijhout
Journal:  Theor Biol Med Model       Date:  2008-04-28       Impact factor: 2.432

10.  Global, Regional, and National Burden and Trends of Down Syndrome From 1990 to 2019.

Authors:  Liyuan Chen; Lifei Wang; Yi Wang; Haishan Hu; Yuan Zhan; Zhilin Zeng; Lidan Liu
Journal:  Front Genet       Date:  2022-07-15       Impact factor: 4.772

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.